Atomistry » Chlorine » PDB 5os5-5oul » 5ou0
Atomistry »
  Chlorine »
    PDB 5os5-5oul »
      5ou0 »

Chlorine in PDB 5ou0: Crystal Structure of Human AKR1B1 Complexed with Nadp+ and Compound 37

Enzymatic activity of Crystal Structure of Human AKR1B1 Complexed with Nadp+ and Compound 37

All present enzymatic activity of Crystal Structure of Human AKR1B1 Complexed with Nadp+ and Compound 37:
1.1.1.21;

Protein crystallography data

The structure of Crystal Structure of Human AKR1B1 Complexed with Nadp+ and Compound 37, PDB code: 5ou0 was solved by A.Cousido-Siah, F.X.Ruiz, A.Mitschler, K.Metwally, A.Podjarny, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 31.50 / 0.94
Space group P 1
Cell size a, b, c (Å), α, β, γ (°) 39.758, 46.771, 47.157, 76.45, 67.76, 78.18
R / Rfree (%) 12.9 / 14.3

Chlorine Binding Sites:

The binding sites of Chlorine atom in the Crystal Structure of Human AKR1B1 Complexed with Nadp+ and Compound 37 (pdb code 5ou0). This binding sites where shown within 5.0 Angstroms radius around Chlorine atom.
In total 2 binding sites of Chlorine where determined in the Crystal Structure of Human AKR1B1 Complexed with Nadp+ and Compound 37, PDB code: 5ou0:
Jump to Chlorine binding site number: 1; 2;

Chlorine binding site 1 out of 2 in 5ou0

Go back to Chlorine Binding Sites List in 5ou0
Chlorine binding site 1 out of 2 in the Crystal Structure of Human AKR1B1 Complexed with Nadp+ and Compound 37


Mono view


Stereo pair view

A full contact list of Chlorine with other atoms in the Cl binding site number 1 of Crystal Structure of Human AKR1B1 Complexed with Nadp+ and Compound 37 within 5.0Å range:
probe atom residue distance (Å) B Occ
A:Cl402

b:17.4
occ:0.82
CL1 A:AV5402 0.0 17.4 0.8
C16 A:AV5402 1.7 14.0 0.8
CL1 A:AV5402 2.3 17.7 0.2
O A:HOH841 2.6 25.1 0.3
C15 A:AV5402 2.7 12.8 0.8
C14 A:AV5402 2.7 14.5 0.2
C14 A:AV5402 2.8 12.3 0.8
C16 A:AV5402 2.8 15.9 0.2
CE3 A:TRP219 3.4 20.1 0.6
CE3 A:TRP219 3.5 20.4 0.4
O A:HOH841 3.6 18.8 0.7
O A:HOH806 3.6 26.4 0.9
O A:HOH756 3.7 18.0 1.0
CZ3 A:TRP219 3.8 20.3 0.4
CD2 A:TRP219 3.9 19.6 0.6
C12 A:AV5402 3.9 12.9 0.2
CB A:TRP219 4.0 19.7 0.6
C13 A:AV5402 4.0 10.9 0.8
C15 A:AV5402 4.0 14.9 0.2
C12 A:AV5402 4.1 11.4 0.8
CZ3 A:TRP219 4.2 20.0 0.6
CG A:TRP219 4.2 19.8 0.6
CD2 A:TRP219 4.2 20.3 0.4
C11 A:AV5402 4.6 10.2 0.8
CH2 A:TRP219 4.6 20.2 0.4
O A:HOH900 4.7 28.9 1.0
CG A:TRP219 4.8 20.4 0.4
O A:HOH620 4.9 19.1 1.0
C11 A:AV5402 4.9 12.0 0.2
C13 A:AV5402 5.0 13.7 0.2
CB A:TRP219 5.0 20.4 0.4
CE2 A:TRP219 5.0 19.4 0.6
CE2 A:TRP219 5.0 20.4 0.4

Chlorine binding site 2 out of 2 in 5ou0

Go back to Chlorine Binding Sites List in 5ou0
Chlorine binding site 2 out of 2 in the Crystal Structure of Human AKR1B1 Complexed with Nadp+ and Compound 37


Mono view


Stereo pair view

A full contact list of Chlorine with other atoms in the Cl binding site number 2 of Crystal Structure of Human AKR1B1 Complexed with Nadp+ and Compound 37 within 5.0Å range:
probe atom residue distance (Å) B Occ
A:Cl402

b:17.7
occ:0.18
CL1 A:AV5402 0.0 17.7 0.2
O A:HOH841 0.4 25.1 0.3
O A:HOH841 1.5 18.8 0.7
C16 A:AV5402 1.8 15.9 0.2
O A:HOH806 2.3 26.4 0.9
CL1 A:AV5402 2.3 17.4 0.8
C16 A:AV5402 2.7 14.0 0.8
C15 A:AV5402 2.8 14.9 0.2
C14 A:AV5402 2.8 14.5 0.2
C14 A:AV5402 2.8 12.3 0.8
O A:HOH620 3.0 19.1 1.0
O A:HOH756 3.3 18.0 1.0
O A:HOH900 3.5 28.9 1.0
C15 A:AV5402 3.7 12.8 0.8
O A:HOH816 3.9 21.0 1.0
C12 A:AV5402 4.0 11.4 0.8
N A:SER302 4.0 17.5 1.0
CB A:SER302 4.1 21.2 1.0
C12 A:AV5402 4.1 12.9 0.2
C13 A:AV5402 4.1 13.7 0.2
OG A:SER302 4.3 21.8 1.0
N A:LEU301 4.4 15.2 1.0
C11 A:AV5402 4.6 12.0 0.2
C13 A:AV5402 4.6 10.9 0.8
CA A:SER302 4.6 18.9 1.0
O A:HOH721 4.7 9.0 0.7
CB A:LEU301 4.7 16.4 1.0
C11 A:AV5402 4.8 10.2 0.8
C A:LEU301 4.9 16.7 1.0
O A:HOH732 4.9 11.7 1.0
CA A:LEU301 4.9 16.0 1.0

Reference:

I.Crespo, J.Gimenez-Dejoz, S.Porte, A.Cousido-Siah, A.Mitschler, A.Podjarny, H.Pratsinis, D.Kletsas, X.Pares, F.X.Ruiz, K.Metwally, J.Farres. Design, Synthesis, Structure-Activity Relationships and X-Ray Structural Studies of Novel 1-Oxopyrimido[4,5-C]Quinoline-2-Acetic Acid Derivatives As Selective and Potent Inhibitors of Human Aldose Reductase. Eur J Med Chem V. 152 160 2018.
ISSN: ISSN 1768-3254
PubMed: 29705708
DOI: 10.1016/J.EJMECH.2018.04.015
Page generated: Fri Jul 26 14:52:11 2024

Last articles

Zn in 9JYW
Zn in 9IR4
Zn in 9IR3
Zn in 9GMX
Zn in 9GMW
Zn in 9JEJ
Zn in 9ERF
Zn in 9ERE
Zn in 9EGV
Zn in 9EGW
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy